Frontiers in Pharmacology | Renal Pharmacology

Original Research

Published on 22 May 2025

Bupropion decreases plasma levels of asymmetric dimethylarginine and ameliorates renal injury by modulation of Ddah1, Oatp4c1, Oct2, and Mate1 in rats with adenine-induced chronic renal injury

in Renal Pharmacology

Lulu Huang
Yun Xiao
Xiaoyu Han
Yang Yu
Chao Zheng
Xiangdong Fang
Qing Li
Fanglan Liu
Chunhua Xia
Yongjie Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1565713

731 views

Systematic Review

Published on 20 May 2025

The preventive effect of sodium-glucose co-transporter-2 inhibitors on atrial fibrillation and atrial flutter in patients with chronic kidney disease: a meta-analysis

in Renal Pharmacology

Qian Yang
Chen Wang
Wenjing Wang
Yanhong Li
Yi Dang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1585491

1,019 views

Original Research

Published on 19 May 2025

Natural products in treating diabetic kidney disease: a visualized bibliometric analysis

in Renal Pharmacology

Tianlong Liu
Xiaolin Li
Yidan Chen
Jinhu Li
Rong Wang
Yi Ding
Minna Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1522074

1,032 views

Original Research

Published on 19 May 2025

Post-marketing safety surveillance of voclosporin: an observational, pharmacovigilance study leveraging faers database study on the safety of voclosporin

in Renal Pharmacology

Zhi Wang
Yanhua Lang
Xuyan Liu
Yuxuan Wang
Leping Shao

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1506760

1,407 views

Review

Published on 14 May 2025

Elucidating the function of clusterin in the progression of diabetic kidney disease

in Renal Pharmacology

Lin Mao
Ruili Yin
Longyan Yang
Dong Zhao

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1573654

789 views

Original Research

Published on 13 May 2025

Renal tubular epithelial cell related partial epithelial-mesenchymal transition in AAⅠ induced renal fibrosis via Wnt7b/β-catenin signaling

in Renal Pharmacology

Yi-Fan Wang
Dan Zheng
Ying Zhang
Xiao-Fen Li
Ming Xia
Hai-Ming Tang
Chun-Hua Huang
Mao-Juan Li
Di-Dong Lou

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1571960

1,080 views

Original Research

Published on 13 May 2025

Stromal vascular fraction inhibits renal fibrosis by regulating metabolism and inflammation in obstructive nephropathy

in Renal Pharmacology

Guang Yue
Yunjie Yang
Hongshuai Jia
Yangyang Wu
Lifei Ma
Xiaoyu Yi
Yuandong Tao
Huixia Zhou

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1559446

783 views

Original Research

Published on 13 May 2025

Network pharmacology and experimental validation to elucidate the pharmacological mechanisms of OATF against kidney stones

in Renal Pharmacology

Sisi Dai
Qi Fang
Hong-Yan Li
Rui Sun
Hui-Yong Zhang
Wei Wu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1575270

1,074 views

Editorial

Published on 07 May 2025

Editorial: Identification of effective biomarkers for diagnosis and treatment of chronic kidney disease: integrating bioinformatics and pharmacological approaches

in Renal Pharmacology

Swayam Prakash Srivastava
Keizo Kanasaki

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1606173

836 views

Original Research

Published on 30 Apr 2025

Huangkui capsules regulate tryptophan metabolism to improve diabetic nephropathy through the Keap1/Nrf2/HO-1 pathway

in Renal Pharmacology

Jiayu Su
Ying Zhang
Xuan Wang
Xiaochao Hu
Ke Zhou
Huimin Zhu
Ehu Liu
Shijia Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1535352

1,585 views

Original Research

Published on 30 Apr 2025

SuoquanYishen formula improves renal cellular senescence by inhibiting YTHDF1-Rubicon axis to promote autophagy in diabetic kidney disease

in Renal Pharmacology

Zijie Yan
Lin Zhang
Tianpeng Ma
Yong Yuan
Yu Kang
Shuman Liu
BoCen Chen
Kai Li
Man Xiao
Yiqiang Xie

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1543277

1,608 views

Original Research

Published on 30 Apr 2025

Integrated metabolomics and network pharmacology analysis to reveal the mechanisms of Wenshenyang decoction in the treatment of chronic kidney disease

in Renal Pharmacology

Ge Jin
Zongjiang Zhao

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1500463

1,558 views

Original Research

Published on 29 Apr 2025

Magnolia kobus DC. Alleviates adenine-induced chronic kidney disease by regulating ferroptosis in C57BL/6 mice

in Renal Pharmacology

Jong Min Kim
Yiseul Kim
Hyun-Jin Na
Haeng Jeon Hur
Sang-Hee Lee
Mi Jeong Sung

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1548660

1,714 views

Original Research

Published on 29 Apr 2025

Synergistic amelioration of renal oxidative stress, inflammation, and fibrosis by combination of metformin and Clinacanthus nutans leave extracts in a type 2 diabetic rat model

in Renal Pharmacology

Pongrapee Laorodphun
Saruda Thongyim
Sureeporn Suriyaprom
Pornchita Maphet
Yingmanee Tragoolpua
Thida Kaewkod
Aussara Panya
Phatchawan Arjinajarn

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1558341

1,082 views

Original Research

Published on 28 Apr 2025

Integrating proteomics and network pharmacology to explore the relevant mechanism of Huangkui capsule in the treatment of chronic glomerulonephritis

in Renal Pharmacology

Chang Qing Wen
Jia Zou
Jia Xuan Li
Fu Jiang Wang
Hai Tao Ge

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1560420

1,108 views

Original Research

Published on 25 Apr 2025

HDAC3 inhibition mitigates acute kidney injury by alleviating RIPK1-mediated programmed necrosis

in Renal Pharmacology

Manman Xie
Rui Hou
Runrun Shan
Xinyu Cheng
Pengcheng Wu
Xiufeng Luo
Yangyang Wei
Li Gao
Xiaoying Liu
Qi Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1546950

1,284 views